𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adrafinil-induced orofacial dyskinesia

✍ Scribed by Stéphane Thobois; Jing Xie; Helena Mollion; Isabelle Benatru; Emmanuel Broussolle


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
48 KB
Volume
19
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4‐month period. They were secondly dramatically improved by tetrabenazine, a presynaptic dopaminergic depleting drug which was introduced after the 4‐month adrafinil‐free period. © 2004 Movement Disorder Society


📜 SIMILAR VOLUMES


Reversible orofacial dyskinesia after of
✍ Jan L. De Bleecker; Veerle L. Vervaet; Angela De Sarro 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

## Abstract We report on a patient who developed orofacial dyskinesia 3 days after starting ofloxacin treatment. The association of orofacial dyskinesia with other fluoroquinolone antibiotics has been reported rarely, chiefly in the elderly with impaired renal or hepatic function or in overdosed pa

Perioral reflexes in orofacial dyskinesi
✍ Dr. Helge Topka; Dr. Mark Hallett 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

In order to assess the clinical utility of trigemino-facial reflexes in lower facial muscles, we studied perioral reflexes to mechanical and electrical stimulation in 13 patients with spasmodic dysphonia and orofacial dyskinesia and in 7 healthy subjects. Mechanical stimulation of the upper lip of a

Fentanyl-induced dyskinesias
✍ Giselle Petzinger; Stephan A. Mayer; Serge Przedborski 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB
Levodopa-induced dyskinesias
✍ Giovanni Fabbrini; Jonathan M. Brotchie; Francisco Grandas; Masahiro Nomoto; Chr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract Levodopa‐induced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFF‐period dystonia, peak‐do